Altered Serotonin Innervation Patterns in the Forebrain of Monkeys Treated with (±)3,4-Methylenedioxymethamphetamine Seven Years Previously: Factors Influencing Abnormal Recovery
George Hatzidimitriou, Una D. Mccann, George A. Ricaurte
Journal of Neuroscience June 15, 1999 DOI: 10.1523/jneurosci.19-12-05096.1999 via OpenAlex
Summary
AI-generated from the abstractSeven years after treatment with MDMA (Ecstasy), squirrel monkeys still showed abnormal brain serotonin innervation patterns, though deficits in some regions were less severe than those observed at 18 months. No loss of serotonin nerve cell bodies in the rostral raphe nuclei was found, indicating that the abnormal patterns are not due to the loss of a particular cell group. Factors influencing recovery of injured serotonin axons include the distance of the affected terminal field from the raphe nuclei, the degree of initial injury, and possibly proximity to myelinated fiber tracts. Additional studies are needed to understand these factors and whether findings apply to humans.
Study at a glance
| Characteristics | Observational cohort Peer reviewed |
|---|---|
| Population | Squirrel monkeys treated with MDMA |
| Intervention | MDMA |
| Duration | 7-year follow-up |
| Topics | MDMA Serotonin |
| Keywords | Axon Neuroscience |
| Citations | 338 |
| Key finding | Seven years after MDMA treatment, squirrel monkeys still had abnormal brain serotonin innervation patterns, though some deficits were less severe than at 18 months, and no loss of serotonin nerve cell bodies in the rostral raphe nuclei was observed. |
Abstract
The recreational drug (±)3,4-methylenedioxymethamphetamine (MDMA, “Ecstasy”) is a potent and selective brain serotonin (5-HT) neurotoxin in animals and, possibly, in humans. The purpose of the present study was to determine whether brain 5-HT deficits persist in squirrel monkeys beyond the 18-month period studied previously and to identify factors that influence recovery of injured 5-HT axons. Seven years after treatment, abnormal brain 5-HT innervation patterns were still evident in MDMA-treated monkeys, although 5-HT deficits in some regions were less severe than those observed at 18 months. No loss of 5-HT nerve cell bodies in the rostral raphe nuclei was found, indicating that abnormal innervation patterns in MDMA-treated monkeys are not the result of loss of a particular 5-HT nerve cell group. Factors that influence recovery of 5-HT axons after MDMA injury are (1) the distance of the affected axon terminal field from the rostral raphe nuclei, (2) the degree of initial 5-HT axonal injury, and possibly (3) the proximity of damaged 5-HT axons to myelinated fiber tracts. Additional studies are needed to better understand these and other factors that influence the response of primate 5-HT neurons to MDMA injury and to determine whether the present findings generalize to humans who use MDMA for recreational purposes.